[1]Kulkarni P,Martson A,Vidya R,et al.Pathophysiological landscape of osteoarthritis[J].Adv Clin Chem,2021(100):37-90.
[2]Fan X,Wu X,Crawford R,et al.Macro,micro,and molecular.Changes of the osteochondral interface in osteoarthritis development[J].Front Cell Dev Biol,2021(9):659654.
[3]Boyde A.The bone cartilage interface and osteoarthritis[J].Calcif Tissue Int,2021,109(3):303-328.
[4]Zhu XB,Chan YT,Yung PSH,et al.Subchondral bone remodeling:A therapeutic target for osteoarthritis[J].Front Cell Dev Biol,2021(8):607764.
[5]Su W,Liu G,Liu X,et al.Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development[J].JCI Insight,2020,5(8):e135446.
[6]Chien SY,Tsai CH,Liu SC,et al.Noggin inhibits IL-1β and BMP-2 expression,and attenuates cartilage degeneration and subchondral bone destruction in experimental osteoarthritis[J].Cells,2020,9(4):927.
[7]Chen L,Yao F,Wang T,et al.Horizontal fissuring at the osteochondral interface:A novel and unique pathological feature in patients with obesity-related osteoarthritis[J].Ann Rheum Dis,2020,79(6):811-888.
[8]Marahleh A,Kitaura H,Ohori F,et al.The osteocyte and its osteoclastogenic potential[J].Front Endocrinol (Lausanne),2023(14):1121727.
[9]Croucher PI,Mcdonald MM,Martin TJ.Bone metastasis:The importance of the neighbourhood[J].Nat Rev Cancer,2016,16(6):373-386.
[10]Liu J,Wu X,Lu J.et al.Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progression[J].Nat Aging,2021,1(4):368-384.
[11]Cherifi C,Latourte A,Vettorazzi S,et al.Inhibition of sphingosine1-phosphate protects mice against chondrocyte catabolism and osteoarthritis[J].Osteoarthritis Cartilage,2021,29(9):1335-1345.
[12]Lfvall H,Newbould H,Karsdal MA,et al.Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes[J].Arthritis Res Ther,2018,20(1):67.
[13]何小文,丁徐,张东华,等.LncRNA GAS5通过TIMP-3启动子甲基化促进软骨胶原蛋白降解的实验研究[J].实用骨科杂志,2021,27(11):999-1004.
[14]Zhang RK,Li GW,Zeng C,et al.Mechanical stress contributes to osteoarthritis development through the activation of transforming growth factor beta 1(TGF-β1)[J].Bone Joint Res,2018,7(11):587-594.
[15]Liu Y,Xie HQ,Shen B.Type H vessels-a bridge connecting subchondral bone remodelling and articular cartilage degeneration in osteoarthritis development[J].Rheumatol Oxf Engl,2023,62(4):1436-1444.
[16]Xie H,Cui Z,Wang L,et al.PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis[J].Nat Med,2014,20(11):1270-1278.
[17]Cui Z,Wu H,Xiao Y,et al.Endothelial PDGF-BB/PDGFR-β signaling promotes osteoarthritis by enhancing angiogenesis-dependent abnormal subchondral bone formation[J].Bone Res,2022,10(1):58.
[18]Zhang H,Wang L,Cui J,et al.Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression[J].Sci Adv,2023,9(14):eabo7868.
[19]Jiang W,Jin Y,Zhang S,et al.PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis[J].Bone Res,2022,10(1):27.
[20]Zhu S,Zhu J,Zhen G,et al.Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain[J].J Clin Invest,2019,129(3):1076-1093.
[21]Li B,Ding T,Chen H,et al.CircStrn3 targeting microRNA-9-5p is involved in the regulation of cartilage degeneration and subchondral bone remodelling in osteoarthritis[J].Bone Joint Res,2023,12(1):33-45.
[22]Youlten SE,Kemp JP,Logan JG,et al.Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease[J].Nat Commun,2021,12(1):2444.
[23]Tanaka T,Miyakoshi Y,Kobayashi Y,et al.Regulation of osteoblast to osteocyte differentiation by cyclin-dependent kinase-1[J].Adv Biol (Weinh),2023,7(12):e2300136.
[24]Jiao Z,Chai H,Wang S,et al.SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis[J].J Mol Med (Berl),2023,101(5):607-620.
[25]Jeong SH,Nguyen KT,Nguyen MT,et al.DMP1 and IFITM5 regulate osteogenic differentiation of MC3T3-E1 on PEO-Treated Ti-6Al-4V-Ca2+/Pi surface[J].ACS Biomater Sci Eng,2023,9(3):1377-1390.
[26]Dai G,Xiao H,Liao J,et al.Osteocyte TGFβ1-Smad 2/3 is positively associated with bone turnover parameters in subchondral bone of advanced osteoarthritis[J].Int J Mol Med,2020,46(1):167-178.
[27]Nguyen J,Tang SY,Nguyen D,et al.Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism[J].PLoS One,2013,8(1):e53813.
[28]Marahleh A,Kitaura H,Ohori F,et al.TNF-α directly enhances osteocyte RANKL expression and promotes osteoclast formation[J].Front Immunol,2019(10):2925.
[29]Ding P,Gao C,Gao Y,et al.Osteocytes regulate senescence of bone and bone marrow[J].Elife,2022(11):e81480.
[30]Liang X,Jin Q,Yang X,et al.Dickkopf-3 and β-catenin play opposite roles in the Wnt/β-catenin pathway during the abnormal subchondral bone formation of human knee osteoarthritis[J].Int J Mol Med,2022,49(4):48.
[31]Zhen G,Guo Q,Li Y,et al.Mechanical stress determines the configuration of TGFbeta activation in articular cartilage[J].Nat Commun,2021,12(1):1706.
[32]Bailey KN,Nguyen J,Yee CS,et al.Mechanosensitive control of articular cartilage and subchondral bone homeostasis in mice requires osteocytic transforming growth factor beta signaling[J].Arthritis Rheumatol,2021,73(3):414-425.
[33]Zhai G.Clinical relevance of biochemical and metabolic changes in osteoarthritis[J].Adv Clin Chem,2021(101):95-120.
[34]Pérez-Lozano ML,Sudre L,Van Eegher S,et al.Gremlin-1 and BMP-4 overexpressed in osteoarthritis drive an osteochondral-remodeling program in osteoblasts and hypertrophic chondrocytes[J].Int J Mol Sci,2022,23(4):2084.
[35]Zhou Z,Ang S,Nie X,et al.Osteoarthritic infrapatellar fat pad aggravates cartilage degradation via activation of p38MAPK and ERK1/2 pathways[J].Inflamm Res,2021,70(10-12):1129-1139.
[36]Dong Y,Wang P,Yang Y,et al.PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-κB signaling[J].Arthritis Res Ther,2020,22(1):201.
[37]Shi J,Zhang C,Yi Z,et al.Explore the variation of MMP3,JNK,p38 MAPKs,and autophagy at the early stage of osteoarthritis[J].IUBMB Life,2016,68(4):293-302.
[38]Li X,Cui L,Chen W,et al.Qiangguyin modulates the OPG/RANKL/RANK pathway by increasing secretin levels during treatment of primary type Ⅰ osteoporosis[J].Evid Based Complement Alternat Med,2021(2021):7114139.
[39]Yasuda H.Discovery of the RANKL/RANK/OPG system[J].J Bone Miner Metab,2021,39(1):2-11.